Archive Newsletter

  1. 02.24.25 -- Integrating Development Processes For Combination Products 2/24/2025
    02/24/25 Drug Delivery Leader Newsletter
  2. 02.17.25 -- Broadening The Range Of Self-Administered Biologics 2/17/2025
    02/17/25 Drug Delivery Leader Newsletter
  3. 02.13.25 -- Frankly Fran: Use-Related Risk Analysis: Considering The FDA Guidance On URRA 2/13/2025
    02/13/25 Drug Delivery Leader Newsletter
  4. 02.12.25 -- Superior Drug Delivery: High Drug Loads And Concentrations For Small And Large Molecules 2/12/2025

    02/12/25 Drug Delivery Leader Newsletter

  5. 02.10.25 -- Defying Dysphagia Via Gel-Based Delivery 2/10/2025
    02/10/25 Drug Delivery Leader Newsletter
  6. 02.03.25 -- Understanding CGMPs For Combination Products 2/3/2025
    02/03/25 Drug Delivery Leader Newsletter
  7. Best of January: Top 5 Insights In Drug Formulation & Delivery 1/30/2025
  8. 01.27.25 -- Enabling In-Home Drug Delivery With SMC's Asmita Khanolkar 1/27/2025
    01/27/25 Drug Delivery Leader Newsletter
  9. 01.20.25 -- 5 Reasons For Pharma Revisits Of Delivery Device Strategies In 2025 1/20/2025
    01/20/25 Drug Delivery Leader Newsletter
  10. 01.15.25 -- Revolutionizing Formulations: Explore Cutting-Edge Nanotechnology & Drug Delivery Solutions 1/15/2025

    01/15/25 Drug Delivery Leader Newsletter